Results 1217 MSM were interviewed (missing data=3), 54,6% would accept participating, 35,3% would deny, and 9,9% stated they were unsure/maybe/depending on more information or assurances before deciding whether to participate in vaccine trials. WTP in HIV vaccine trial was similar across age groups (p=.450) and race/ethnicity (p=.534). There was no patterned difference among those who self-identified as homosexual, bisexual or transgender (p=.542) as well as among those who would have sex with an HIV-infected person, the size of their HIV-infected network (p=.251). Although not significant (p=0.06) a trend was suggested with WTP and the level of education of the head of the household, as years of education increased greater WTP.
Conclusion
Findings indicate that, despite the lack of success in recent phase II/III trials, there is substantial WTP in HIV vaccine studies, expressing the hope for an effective vaccine retain a pool of potential volunteers among the most vulnerable population. Subsequent analysis should focus on association with behavioral aspects, as risk behaviors, experience of discrimination due to sexuality and WTP. 
